The Impact of Exposure Therapy on Resting Heart Rate and Heart Rate Reactivity among Active Duty Soldiers with PTSD.
Posttraumatic stress disorder (PTSD) is linked to poor health, including cardiovascular disease (CVD). These effects may be a result of increased tonic cardiovascular function and cardiovascular reactivity (CVR). Despite PTSD's negative health burden, relatively little is known about whether frontline treatments for PTSD may alleviate cardiovascular risk. The current study was a secondary analysis of a larger intervention study of active duty soldiers with PTSD (N = 104; mean age = 30.6 years, SD = 6.7; 6% women) randomized to an exposure therapy-either prolonged exposure (PE) or virtual reality exposure (VRE)-or a waitlist control condition. We examined change in participants' resting heart rate (HR) and HR reactivity from baseline (prior to randomization) to mid- and post-treatment using residualized change regression models. The results of the study demonstrated decreased resting HR (B = -5.06, p = .024) and HR reactivity (B = -2.46, p = .005) from baseline to post-treatment for PE and VRE relative to waitlist. Exploratory analyses found that change in resting HR and HR reactivity were not significantly correlated with either self-reported or clinician-rated PTSD symptom change. These results suggest that PE and VRE for PTSD may alleviate some cardiovascular health risk associated with PTSD improving cardiovascular functioning.RCT Registration: The study was registered at ClinicalTrials.gov (identifier: NCT01193725).